- CRS Publications
- News
News
Authors:
Date:
Business Wire: July 27, 2017 – HAYWARD, CA, U.S.A. – Aradigm Corporation (NASDAQ: ARDM) (the “company”) today announced it has submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE)…
Authors:
Date:
PRNewswire: July 26, 2017 – KARLSRUHE, Germany – To meet growing demand for innovative drug delivery systems in the pharmaceutical industry, drug formulation scientists can now use the first commercially available, fully integrated solution for polymerbased drug implant development and production…
Authors:
Date:
Business Wire: July 26, 2017 – NEW YORK, NY, U.S.A. – Ophthotech Corporation (Nasdaq: OPHT) today announced that the company is pursuing a strategy to leverage its clinical experience and retina expertise to identify and develop therapies to treat multiple orphan ophthalmic diseases for which there…
Authors:
Date:
PRNewswire: July 25, 2017 – STELLENBOSCH, South Africa – AzarGen Biotechnologies (Pty) Ltd. (Stellenbosch, South Africa) announced that it has received grant status for the patent application Production of Human Pulmonary Surfactant Protein-B in Plants (EP3013963) from the European Patent Office.…
Authors:
Date:
PRNewswire: July 24, 2017 – TEL-AVIV, Israel – BioLight Life Sciences Ltd. (TASE: BOLT) (“BioLight”), an emerging global ophthalmic company focused on the discovery, development, and commercialization of ophthalmic products and product candidates, announced today successful results from its…
Authors:
Date:
Business Wire: July 24, 2017 – JERUSALEM, Israel – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Vagifem® 1 (estradiol vaginal inserts), 10 mcg in the United States. Estradiol vaginal inserts are an estrogen indicated for the treatment…
